You are here: Industry Insights > Vaccine

News List

Race to find a viable vaccine: Can Indian firms rise to the challenge? expresspharma
August 18, 2020
Juilee Dandekar, Sector Expert - Healthcare, Business Research & Advisory, Aranca gives an overview of India’s capabilities to develop and manufacture vaccines.
Elios Cancer Vaccine Demonstrates Long-Term Survival Benefit Among High-Risk Melanoma Patients americanpharmaceuticalreview
August 12, 2020
Elios Therapeutics announced final data from a prospective, randomized, double-blind, placebo-controlled Phase IIb clinical trial ...
Novavax and Serum Institute of India Announce Collaboration contractpharma
August 11, 2020
Serum Institute gains exclusive rights to commercialize in India and non-exclusive rights to commercialize in other LMIC countries.
Aurobindo Pharma joins COVID-19 vaccine hunt expresspharma
August 10, 2020
The company’s vaccine candidate has been shortlisted for BIRAC funding, will launch final product by the end of 2022.
Policymakers to identify groups of people who will get priority for COVID-19 vaccine expresspharma
August 03, 2020
Four major challenges await India once a vaccine is available, i.e. prioritisation and fair distribution to vulnerable groups; logistics of vaccine rollout, including cold chain; stockpiling and training people who will administer this vaccine: ICMR Head.
Russia readying for mass vaccination against COVID-19 in October expresspharma
August 03, 2020
Health Minister, Mikhail Murashko said doctors and teachers would be the first to be vaccinated.
GSK sees dip in second-quarter sales pharmatimes
July 31, 2020
GlaxoSmithKline has reported group sales of £7.6 billion for the second quarter of 2020, marking a slip of 2% from a year ago, reflecting expected disruption from COVID-19.
IDT Biologika Fills SARS-CoV-2 Vaccine Candidate contractpharma
July 30, 2020
IDT Biologika filled the second clinical batch of a newly-developed vaccine candidate against the coronavirus SARS-CoV-2 in Dessau.
Thermo Fisher Scientific Strengthens its Global Response to COVID-19 and continues to Support Development and Production of Therapeutics and Vaccines expresspharma
July 30, 2020
Thermo Fisher Scientific, the world leader in serving science, continues to expand global capacity and capabilities across its leading pharma services network to support customers in government, industry and academia as they accelerate development and ...
Animal replacement method for vaccine testing developed by Intravacc and Leiden University expresspharma
July 27, 2020
As a result of the Covid-19 pandemic, some 400 therapies and vaccines against this virus are currently being developed worldwide. This affects the number of laboratory animals used in studies.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page